EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,712 | -28.5% | 13,514 | +4.3% | 0.00% | – |
| Q1 2023 | $367,590 | +6.0% | 12,957 | +9.2% | 0.00% | – |
| Q4 2022 | $346,785 | +51.4% | 11,864 | +37.0% | 0.00% | – |
| Q3 2022 | $229,000 | -39.4% | 8,661 | +1.8% | 0.00% | – |
| Q2 2022 | $378,000 | -13.9% | 8,507 | -4.0% | 0.00% | – |
| Q1 2022 | $439,000 | -0.9% | 8,864 | +2.0% | 0.00% | – |
| Q4 2021 | $443,000 | -7.7% | 8,690 | +1.2% | 0.00% | – |
| Q3 2021 | $480,000 | +12.1% | 8,589 | -14.2% | 0.00% | – |
| Q2 2021 | $428,000 | +0.9% | 10,006 | -1.3% | 0.00% | – |
| Q1 2021 | $424,000 | -53.2% | 10,137 | -47.8% | 0.00% | – |
| Q4 2020 | $906,000 | -14.1% | 19,434 | -21.8% | 0.00% | -100.0% |
| Q3 2020 | $1,055,000 | -94.7% | 24,855 | -94.1% | 0.00% | -92.9% |
| Q2 2020 | $20,060,000 | +7.7% | 418,092 | +3.2% | 0.01% | -12.5% |
| Q1 2020 | $18,628,000 | +28.1% | 404,943 | +67.3% | 0.02% | +45.5% |
| Q4 2019 | $14,546,000 | +9.6% | 242,117 | +3.2% | 0.01% | 0.0% |
| Q3 2019 | $13,269,000 | +1241.7% | 234,560 | +1220.6% | 0.01% | +1000.0% |
| Q2 2019 | $989,000 | +146.6% | 17,761 | +123.4% | 0.00% | – |
| Q1 2019 | $401,000 | +31.5% | 7,949 | +4.6% | 0.00% | – |
| Q4 2018 | $305,000 | -69.1% | 7,596 | -46.7% | 0.00% | -100.0% |
| Q3 2018 | $987,000 | +2.5% | 14,242 | +11.9% | 0.00% | 0.0% |
| Q2 2018 | $963,000 | +100.2% | 12,731 | +39.5% | 0.00% | – |
| Q1 2018 | $481,000 | -10.4% | 9,128 | -9.2% | 0.00% | – |
| Q4 2017 | $537,000 | -36.8% | 10,057 | -29.4% | 0.00% | -100.0% |
| Q3 2017 | $850,000 | -46.5% | 14,241 | -29.3% | 0.00% | -50.0% |
| Q2 2017 | $1,590,000 | -35.8% | 20,156 | -32.5% | 0.00% | 0.0% |
| Q1 2017 | $2,476,000 | -13.1% | 29,842 | -16.9% | 0.00% | -33.3% |
| Q4 2016 | $2,848,000 | +16.2% | 35,902 | +2.5% | 0.00% | +50.0% |
| Q3 2016 | $2,452,000 | +50.6% | 35,015 | -16.5% | 0.00% | 0.0% |
| Q2 2016 | $1,628,000 | -36.7% | 41,934 | -33.9% | 0.00% | -33.3% |
| Q1 2016 | $2,570,000 | +408.9% | 63,465 | +1014.6% | 0.00% | +200.0% |
| Q4 2015 | $505,000 | +95.0% | 5,694 | +63.2% | 0.00% | – |
| Q3 2015 | $259,000 | -71.5% | 3,488 | -68.9% | 0.00% | -100.0% |
| Q2 2015 | $908,000 | +50.8% | 11,228 | -21.9% | 0.00% | 0.0% |
| Q1 2015 | $602,000 | – | 14,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |